Case Report
 
A case of simultaneously developed sweet's syndrome and systemic lupus erythematosus in a man
Hiroyuki Hounoki1, Maiko Okumura2, Koichiro Shinoda1, Reina Ogawa2, Hirofumi Taki1, Kazuyuki Tobe1, Kyoko Shimizu3, Teruhiko Makino3, Tadamichi Shimizu3
1First Department of Internal Medicine, University of Toyama, 2630 Sugitani, Toyama, Toyama 930-0194, Japan.
2Department of Dermatology, University of Toyama, 2630 Sugitani, Toyama, Toyama 930-0194, Japan..

doi:10.5348/ijcri-2012-09-180-CR-10

Address correspondence to:
Hirofumi Taki
First Department of Internal Medicine
University of Toyama, 2630 Sugitani
Toyama, Toyama 930-0194
Japan
Phone: +81 76 434 7287
Fax: +81 76 434 5025
Email: htaki-tym@umin.ac.jp

Access full text article on other devices

  Access PDF of article on other devices

[HTML Abstract]   [PDF Full Text] [Print This Article]
[Similar article in Pumed] [Similar article in Google Scholar]


How to cite this article:
Hounoki H, Okumura M, Shinoda K, Ogawa R, Taki H, Tobe K, Shimizu K, Makino T, Shimizu T. A case of simultaneously developed sweet's syndrome and systemic lupus erythematosus in a man. International Journal of Case Reports and Images 2012;3(9):36–38.


Abstract
Introduction: Sweet's syndrome is characterized by the development of tender, erythematous plaques, fever, arthralgia and leukocytosis. Sweet's syndrome is reported to be associated with underlying infections, malignant neoplasms, pregnancy, drugs, and autoimmune diseases. However, Sweet's syndrome associated with systemic lupus erythematosus has been rarely reported. Although both Sweet's syndrome and systemic lupus erythematosus predominantly occur in women, we are reporting a case of simultaneously developed Sweet's syndrome and systemic lupus erythematosus in a man.
Case Report: A 48-year-old previously healthy man was admitted for intermittent fevers, arthralgias, and eruption. Laboratory investigations revealed elevated C-reactive protein, lymphocytopenia, and low complements with elevated immune complex. Antinuclear antibodies, anti-DNA antibodies were positive. Systemic lupus erythematosus was diagnosed based on the presence of arthritis, lymphopenia, anti-DNA antibodies and antinuclear antibodies. A biopsy specimen from an erythematous papule from the right sole showed a slight lichenification and an infiltration of neutrophils and lymphocytes in dermis without leukocytoclastic vasculitis. Thus, this case also met the modified criteria for Sweet's syndrome proposed by von den Driesch. Prednisolone was begun at a dose of 20 mg/day, resulting in diminishing skin eruption and resolution of arthralgia.
Conclusion: Sweet's syndrome is categorized into classical, drug-induced, and malignancy-associated form. Only one case of concurrence of classical Sweet's syndrome and systemic lupus erythematosus has been reported in a man. This is the second case of coincidence of classical Sweet's syndrome and systemic lupus erythematosus in an adult man.

Key Words: Sweet's syndrome, Systemic lupus erythematosus, Erythematous plaques, Arthralgia


Introduction

Sweet's syndrome, or acute febrile neutrophilic dermatosis, was first described by Sweet RD in 1964. [1] This syndrome is characterized by the development of tender, erythematous plaques, fever, arthralgia and leukocytosis. [2] [3] The syndrome is reported to be associated with underlying infections, malignant neoplasms, pregnancy and drugs. [2] [3] In addition, Sweet's syndrome is also associated with autoimmune diseases. [2] [3] However, Sweet's syndrome associated with systemic lupus erythematosus (SLE) has been rarely reported. [4] [5] [6] Here, a case of simultaneously developed Sweet's syndrome and SLE in a man is reported.


Case Report

A 48-year-old previously healthy man was admitted for intermittent fevers, arthralgias, and eruptions. He had never taken any meditations before occurrence of the symptoms. Laboratory investigations were C-reactive protein 2.31 mg/dL (normal range: <0.3 mg/dL), white blood cells 4300/mm3 with lymphocytes 830/mm3, CH50 18 U/mL (normal range: 30–46 U/mL), C3 37.0 mg/dL (normal range: 71–129 mg/dL), C4 5.7 mg/dL (normal range: 12–34 mg/dL) and immune complex 165.0 µg/mL (normal range: <3.0 µg/mL). Viral markers for hepatitis were negative. Antinuclear antibodies (ANA), anti-DNA antibodies were positive at 1:40 speckled pattern and 19 U/mL (normal range: <10 U/mL), respectively. Anti-SS-A antibodies, anti-SS-B antibodies, antineutrophil cytoplasmic antibodies against proteinase 3 and myeloperoxidase, anti-RNP antibodies, anti-Sm antibodies, anti-Jo-1 antibodies, anti-cardiolipin antibodies and lupus anticoaglant were all negative. Screening for malignancy by means of gallium scintigraphy, chest and abdominal computed tomography, and gastrointestinal fiberscope indicated no evidence of malignancy. Leukocytosis, which is a predominant feature of Sweet's syndrome, was not always observed in this case [1]. Rather, lymphopenia in addition to positive ANA and anti-DNA antibodies with hypocomplimentemia and high levels of immune complex in the serum were observed in this case. SLE was diagnosed based on the presence of arthritis, lymphopenia, ANA and anti-DNA antibodies according to the revised classification criteria of SLE.

A biopsy specimen from an erythematous papule from the right sole (Figure 1) showed a slight lichenification and an infiltration of neutrophils and lymphocytes in dermis without leukocytoclastic vasculitis (Figure 2A–B). Furthermore, immunofluorescence was positive for complement deposition at dermal-epidermal junction, indication a positive for lupus band test. This finding further helps to confirm the diagnosis of SLE. Oral administration of prednisolone was begun at a dose of 20 mg/day, resulting in diminishing skin eruptions and a resolution of arthralgia. Thus, this case met the modified criteria for Sweet's syndrome proposed by von den Driesch [1].


Cursor on image to zoom/Click text to open image
Figure 1: Erythematous plaques on the right sole.



Cursor on image to zoom/Click text to open image
Figure 2: Hematoxylin-eosin stained histopathological images. Skin lesion showed a slight lichenification and an infiltration of neutrophils and lymphocytes in dermis without leukocytoclastic vasculitis in (A) low-power (original magnification X40), and (B) high-power (original magnification X400) magnification.



Discussion

Sweet's syndrome is reported to be associated with underlying infections, malignant neoplasms, pregnancy, drugs, and autoimmune diseases. [2] [3] Thus, Sweet's syndrome is categorized into classical, drug-induced, and malignancy-associated form. We diagnosed this case as a classical Sweet's syndrome.

The characteristic histopathologic features of Sweet's syndrome are diffuse infiltrate of predominantly neutrophils with leukocytoclasia, papillary dermal edema, swollen endothelial cells and an absence of leukocytoclastic vasculitis. The pathological findings of this patient were consistent with Sweet's syndrome. In addition, immunofluoresence of immunoglobulin and complement deposition at the basement membrane of the skin was positive along with serum hypocomplementemia and high immune complex levels, suggesting a coexistence of SLE.

Concurrence of lupus including drug-induced lupus and subacute cutaneous lupus with Sweet's syndrome had been reported previously in adults. [7] [8] However, only three cases of concurrence of classical Sweet's syndrome and SLE have been reported, in whom two are women and one is a man. [4] [5] [6] Although both classical Sweet's syndrome and SLE predominantly occur in women, this is the second case of coincidence of classical Sweet's syndrome and SLE in an adult man.


Conclusion

Sweet's syndrome associated with SLE has been rarely reported. This is a second case of concurrence of classical Sweet's syndrome and SLE observed in a male patient.


References
  1. von den Driesch P. Sweet's syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol 1994;31:535–6.   [CrossRef]   [Pubmed]    Back to citation no. 1
  2. Sweet RD. An acute febrile neutrophilic dermatitis. Br J Dermatol 1964;76:349–56.   [CrossRef]   [Pubmed]    Back to citation no. 2
  3. Cohen PR. Sweet's syndrome–a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis 2007;2:34.   [CrossRef]   [Pubmed]    Back to citation no. 3
  4. Hou TY, Chang DM, Gao HW, Chen CH, Chen HC, Lai JH. Sweet's syndrome as an initial presentation in systemic lupus erythematosus: a case report and review of the literature. Lupus 2005;14:399–402.   [CrossRef]   [Pubmed]    Back to citation no. 4
  5. Gollol-Raju N, Bravin M, Crittenden D. Sweet's syndrome and systemic lupus erythematosus. Lupus 2009;18:377–8.   [CrossRef]   [Pubmed]    Back to citation no. 5
  6. Fernandes NF, Castelo-Soccio L, Kim EJ, Werth VP. Sweet syndrome associated with new-onset systemic lupus erythematosus in a 25-year-old man. Arch Dermatol 2009;145:608–9.   [CrossRef]   [Pubmed]    Back to citation no. 6
  7. Goette GK. Sweet's syndrome in subacute cutaneous lupus erythematosus. Arch Dermatol 1985;121:789–1.   [CrossRef]   [Pubmed]    Back to citation no. 7
  8. Sequeria W, Polisky RB, Alrenga DP. Neutrophilic dermatitis (Sweet's syndrome); association with a hydralazine-induced lupus syndrome. Am J Med 1986;81:558–60.   [CrossRef]   [Pubmed]    Back to citation no. 8

[HTML Abstract]   [PDF Full Text]

Author Contributions:
Hiroyuki Hounoki – Acquisition of data, Analysis and interpretation of data, Critical revision of the article, Final approval of the version to be published
Maiko Okumura – Acquisition of data, Analysis and interpretation of data, Final approval of the version to be published
Koichiro Shinoda – Acquisition of data, Analysis and interpretation of data, Final approval of the version to be published
Reina Ogawa – Acquisition of data, Analysis and interpretation of data, Final approval of the version to be published
Hirofumi Taki – Acquisition of data, Analysis and interpretation of data, Drafting the article, Critical revision of the article, Final approval of the version to be published
Kazuyuki Tobe – Final approval of the version to be published
Kyoko Shimizu – Acquisition of data, Analysis and interpretation of data, Final approval of the version to be published
Teruhiko Makino – Acquisition of data, Analysis and interpretation of data, Final approval of the version to be published
Tadamichi Shimizu – Acquisition of data, Analysis and interpretation of data, Final approval of the version to be published
Guarantor of submission:
The corresponding author is the guarantor of submission.
Source of support:
None
Conflict of interest:
Authors declare no conflict of interest
Copyright:
© Hiroyuki Hounoki et al. 2012; This article is distributed the terms of Creative Commons Attribution License which permits unrestricted use, distribution and reproduction in any means provided the original authors and original publisher are properly credited. (Please see Copyright Policy for more information.)